Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017
Diagnostic Evaluation of Patients with a Brain Mass as the Presenting Manifestation of Cancer
Neurol 65:908-911, Mavrakis,A.N.,et al, 2005
Practice Parameter: Anticonvulsant Prophylaxis in Patients With Newly Diagnosed Brain Tumors
Neurol 54:1886-1893, Glantz,M.J.,et al, 2000
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Primary Brain Tumors:Review of Etiology Diagnosis and Treatment
Am Fam Physician 49:787-797, Newton,H.B., 1994
Brain Tumors in Children
J Pediatr 114:511-519, Kadota,R.P.,et al, 1989